#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA1042727	B	Inhibition of recombinant Taspase 1 assessed as accumulation of emitted fluorescence by FRET assay		4		single protein format	Scientific Literature
2.	ALA1042728	B	Inhibition of recombinant Taspase 1 assessed as accumulation of emitted fluorescence at 100 uM by FRET assay		3		single protein format	Scientific Literature
3.	ALA1042729	B	Inhibition of recombinant Taspase 1 assessed as loss of processing and accumulation of full length p45 fragment by radiographic in vitro cleavage assay added 30 mins before translated p45MLL		4		single protein format	Scientific Literature
4.	ALA3992262	B	Inhibition of recombinant Taspase1 (unknown origin) using [35S]-methionine labeled human MLL1 (2400-2900 residues) as substrate preincubated for 30 mins followed by substrate addition measured after 30 mins by SDS-PAGE based autoradiography	Homo sapiens	4		single protein format	Patent Bioactivity Data
5.	ALA3992263	B	Inhibition of recombinant Taspase1 (unknown origin) at 0.1 to 250 uM using [35S]-methionine labeled human MLL1 (2400-2900 residues) as substrate preincubated for 30 mins followed by substrate addition measured after 30 mins by SDS-PAGE based autoradiography	Homo sapiens	1		single protein format	Patent Bioactivity Data
6.	ALA3992264	B	Inhibition of recombinant Taspase1 (unknown origin) at 1 mM using [35S]-methionine labeled human MLL1 (2400-2900 residues) as substrate preincubated for 30 mins followed by substrate addition measured after 30 mins by SDS-PAGE based autoradiography	Homo sapiens	1		single protein format	Patent Bioactivity Data
7.	ALA3992266	B	Inhibition of recombinant Taspase1 (unknown origin) at 10 uM using [35S]-methionine labeled human MLL1 (2400-2900 residues) as substrate preincubated for 30 mins followed by substrate addition measured after 30 mins by SDS-PAGE based autoradiography	Homo sapiens	1		single protein format	Patent Bioactivity Data
8.	ALA3992267	B	Inhibition of recombinant Taspase1 (unknown origin) up to 0.1 mM using [35S]-methionine labeled human MLL1 (2400-2900 residues) as substrate preincubated for 30 mins followed by substrate addition measured after 30 mins by SDS-PAGE based autoradiography	Homo sapiens	1		single protein format	Patent Bioactivity Data
9.	ALA3992268	B	Covalent irreversible inhibition of recombinant Taspase1 (unknown origin) at 0.1 mM using [35S]-methionine labeled human MLL1 (2400-2900 residues) as substrate preincubated for 15 to 60 mins followed by substrate addition measured after 30 mins by SDS-PAGE based autoradiography	Homo sapiens	1		single protein format	Patent Bioactivity Data
10.	ALA3992269	B	Inhibition of recombinant Taspase1 (unknown origin) at 10 to 1000 uM using [35S]-methionine labeled human MLL1 (2400-2900 residues) as substrate preincubated for 30 mins followed by substrate addition measured after 30 mins by SDS-PAGE based autoradiography	Homo sapiens	2		single protein format	Patent Bioactivity Data
11.	ALA3992273	B	Non-competitive inhibition of recombinant Taspase1 (unknown origin) using FRPR as substrate preincubated with compound followed by substrate addition by fluorescence spectrometry	Homo sapiens	1		single protein format	Patent Bioactivity Data
12.	ALA3992283	B	Inhibition of recombinant Taspase1 (unknown origin) using FRPR as substrate preincubated with compound followed by substrate addition by fluorescence spectrometry	Homo sapiens	7		single protein format	Patent Bioactivity Data